Literature DB >> 33578875

Predicting the Risk of Postoperative Complications in Patients Undergoing Minimally Invasive Resection of Primary Liver Tumors.

Philipp K Haber1, Christoph Maier2, Anika Kästner1, Linda Feldbrügge1, Santiago Andres Ortiz Galindo1, Dominik Geisel2, Uli Fehrenbach2, Matthias Biebl1, Felix Krenzien1, Christian Benzing1, Wenzel Schöning1, Johann Pratschke1, Moritz Schmelzle1.   

Abstract

Minimal-invasive techniques are increasingly applied in clinical practice and have contributed towards improving postoperative outcomes. While comparing favorably with open surgery in terms of safety, the occurrence of severe complications remains a grave concern. To date, no objective predictive system has been established to guide clinicians in estimating complication risks as the relative contribution of general patient health, liver function and surgical parameters remain unclear. Here, we perform a single-center analysis of all consecutive patients undergoing laparoscopic liver resection for primary hepatic malignancies since 2010. Among the 210 patients identified, 32 developed major complications. Several independent predictors were identified through a multivariate analysis, defining a preoperative model: diabetes, history of previous hepatectomy, surgical approach, alanine aminotransferase levels and lesion entity. The addition of operative time and whether conversion was required significantly improved predictions and were thus incorporated into the postoperative model. Both models were able to identify patients with major complications with acceptable performance (area under the receiver-operating characteristic curve (AUC) for a preoperative model = 0.77 vs. postoperative model = 0.80). Internal validation was performed and confirmed the discriminatory ability of the models. An easily accessible online tool was deployed in order to estimate probabilities of severe complication without the need for manual calculation.

Entities:  

Keywords:  cholangiocarcinoma; hepatocellular carcinoma; laparoscopic liver surgery; risk score

Year:  2021        PMID: 33578875      PMCID: PMC7916554          DOI: 10.3390/jcm10040685

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  30 in total

1.  Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection.

Authors:  M C Halls; G Berardi; F Cipriani; L Barkhatov; P Lainas; S Harris; M D'Hondt; F Rotellar; I Dagher; L Aldrighetti; R I Troisi; B Edwin; M Abu Hilal
Journal:  Br J Surg       Date:  2018-05-08       Impact factor: 6.939

Review 2.  Laparoscopic liver resection: a review of current indications and surgical techniques.

Authors:  Chenyang Jia; Hongyu Li; Ningyuan Wen; Junhua Chen; Yonggang Wei; Bo Li
Journal:  Hepatobiliary Surg Nutr       Date:  2018-08       Impact factor: 7.293

3.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.

Authors:  John Bridgewater; Peter R Galle; Shahid A Khan; Josep M Llovet; Joong-Won Park; Tushar Patel; Timothy M Pawlik; Gregory J Gores
Journal:  J Hepatol       Date:  2014-03-27       Impact factor: 25.083

4.  A novel difficulty scoring system for laparoscopic liver resection.

Authors:  Daisuke Ban; Minoru Tanabe; Hiromitsu Ito; Yuichiro Otsuka; Hiroyuki Nitta; Yuta Abe; Yasushi Hasegawa; Toshio Katagiri; Chisato Takagi; Osamu Itano; Hironori Kaneko; Go Wakabayashi
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-10       Impact factor: 7.027

5.  Liver Transplantation and Liver Resection for Cirrhotic Patients with Hepatocellular Carcinoma: Comparison of Long-Term Survivals.

Authors:  Felix Krenzien; Moritz Schmelzle; Benjamin Struecker; Nathanael Raschzok; Christian Benzing; Maximilian Jara; Marcus Bahra; Robert Öllinger; Igor M Sauer; Andreas Pascher; Johann Pratschke; Andreas Andreou
Journal:  J Gastrointest Surg       Date:  2018-01-23       Impact factor: 3.452

6.  Intrahepatic cholangiocarcinoma as the new field of implementation of laparoscopic liver resection programs. A comparative propensity score-based analysis of open and laparoscopic liver resections.

Authors:  Mohammed Abu Hilal; Luca Aldrighetti; Francesca Ratti; Arab Rawashdeh; Federica Cipriani; John Primrose; Guido Fiorentini
Journal:  Surg Endosc       Date:  2020-04-27       Impact factor: 4.584

7.  Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis.

Authors:  Dong Ho Lee; Jeong Min Lee; Jae Young Lee; Se Hyung Kim; Jung Hwan Yoon; Yoon Jun Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2013-10-30       Impact factor: 11.105

8.  Financial Impact of the Robotic Approach in Liver Surgery: A Comparative Study of Clinical Outcomes and Costs Between the Robotic and Open Technique in a Single Institution.

Authors:  Despoina Daskalaki; Raquel Gonzalez-Heredia; Marc Brown; Francesco M Bianco; Ivo Tzvetanov; Myriam Davis; Jihun Kim; Enrico Benedetti; Pier C Giulianotti
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2017-02-10       Impact factor: 1.878

Review 9.  Laparoscopic liver resection: indications, limitations, and economic aspects.

Authors:  Moritz Schmelzle; Felix Krenzien; Wenzel Schöning; Johann Pratschke
Journal:  Langenbecks Arch Surg       Date:  2020-07-01       Impact factor: 3.445

Review 10.  Single incision laparoscopic liver resection (SILL) - a systematic review.

Authors:  Christian Benzing; Felix Krenzien; Georgi Atanasov; Daniel Seehofer; Robert Sucher; Ricardo Zorron; Johann Pratschke; Moritz Schmelzle
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2015-12-15
View more
  1 in total

Review 1.  Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach.

Authors:  Felix Krenzien; Nora Nevermann; Alina Krombholz; Christian Benzing; Philipp Haber; Uli Fehrenbach; Georg Lurje; Uwe Pelzer; Johann Pratschke; Moritz Schmelzle; Wenzel Schöning
Journal:  Cancers (Basel)       Date:  2022-01-12       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.